FI943100A - Ansamycin derivatives as anthionogenic and anti-cancer agents - Google Patents
Ansamycin derivatives as anthionogenic and anti-cancer agents Download PDFInfo
- Publication number
- FI943100A FI943100A FI943100A FI943100A FI943100A FI 943100 A FI943100 A FI 943100A FI 943100 A FI943100 A FI 943100A FI 943100 A FI943100 A FI 943100A FI 943100 A FI943100 A FI 943100A
- Authority
- FI
- Finland
- Prior art keywords
- anthionogenic
- cancer agents
- ansamycin derivatives
- ansamycin
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8506593A | 1993-06-29 | 1993-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI943100A0 FI943100A0 (en) | 1994-06-28 |
FI943100A true FI943100A (en) | 1994-12-30 |
Family
ID=22189242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI943100A FI943100A (en) | 1993-06-29 | 1994-06-28 | Ansamycin derivatives as anthionogenic and anti-cancer agents |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0706516A1 (en) |
JP (1) | JP2794342B2 (en) |
CA (1) | CA2166320A1 (en) |
FI (1) | FI943100A (en) |
WO (1) | WO1995001342A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU764603B2 (en) | 1998-07-17 | 2003-08-21 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Water-soluble drugs and methods for their production |
EP1169319A4 (en) * | 1999-04-09 | 2005-02-09 | Sloan Kettering Institutefor C | Methods and compositions for degradation and/or inhibition of her-family tyrosine kinases |
WO2002036574A1 (en) * | 2000-11-06 | 2002-05-10 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Geldanamycin derivatives useful for the treatment of cancer |
EP1373215B1 (en) * | 2001-03-30 | 2006-07-26 | THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH | Geldanamycin derivatives useful for treating cancer |
WO2003013430A2 (en) * | 2001-08-06 | 2003-02-20 | Kosan Biosciences, Inc. | Benzoquinone ansamycins |
EP1923061A1 (en) | 2001-09-24 | 2008-05-21 | Conforma Therapeutic Corporation | Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins |
KR20040054692A (en) | 2001-09-24 | 2004-06-25 | 콘포마 세러퓨틱스 코포레이션 | Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins |
ATE433961T1 (en) | 2002-02-08 | 2009-07-15 | Conforma Therapeutics Corp | ANSAMYCINS WITH IMPROVED PHARMACOLOGICAL AND BIOLOGICAL PROPERTIES |
CA2518836A1 (en) * | 2003-03-13 | 2004-09-30 | Conforma Therapeutics Corporation | Drug formulations having long and medium chain triglycerides |
CA2545457A1 (en) | 2003-11-12 | 2005-06-23 | Kosan Biosciences, Inc. | 11-o-methylgeldanamycin compounds |
US6875863B1 (en) | 2003-11-12 | 2005-04-05 | Kosan Biosciences, Inc. | 11-O-methylgeldanamycin compounds |
US6887993B1 (en) | 2003-11-12 | 2005-05-03 | Kosan Biosciences, Inc. | 11-O-methylgeldanamycin compounds |
US6855705B1 (en) | 2003-11-12 | 2005-02-15 | Kosan Biosciences, Inc. | 11-O-methylgeldanamycin compounds |
US20060019941A1 (en) * | 2003-12-23 | 2006-01-26 | Infinity Pharmaceuticals, Inc. | Analogs of benzoquinone-containing ansamycins and methods of use thereof |
RU2484086C9 (en) | 2003-12-23 | 2013-08-20 | Инфинити Дискавэри, Инк. | Analogues of benzoquinone-containing ansamycins (versions), method for production thereof, pharmaceutical composition (versions) and cancer treatment method (versions) |
PE20081506A1 (en) | 2006-12-12 | 2008-12-09 | Infinity Discovery Inc | ANSAMYCIN FORMULATIONS |
JP5583680B2 (en) | 2008-10-15 | 2014-09-03 | インフィニティー ファーマスーティカルズ インコーポレイテッド | Ansamycin hydroquinone composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3595955A (en) * | 1969-03-26 | 1971-07-27 | Upjohn Co | Geldanamycin and process for producing same |
US3987035A (en) * | 1974-04-05 | 1976-10-19 | University Of Illinois Foundation | Biologically active compounds |
US4261989A (en) * | 1979-02-19 | 1981-04-14 | Kaken Chemical Co. Ltd. | Geldanamycin derivatives and antitumor drug |
CA2127457A1 (en) * | 1992-01-06 | 1993-07-22 | Walter P. Cullen | Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone |
-
1994
- 1994-06-16 EP EP94916372A patent/EP0706516A1/en not_active Withdrawn
- 1994-06-16 WO PCT/IB1994/000160 patent/WO1995001342A1/en not_active Application Discontinuation
- 1994-06-16 JP JP7503379A patent/JP2794342B2/en not_active Expired - Lifetime
- 1994-06-16 CA CA002166320A patent/CA2166320A1/en not_active Abandoned
- 1994-06-28 FI FI943100A patent/FI943100A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPH08506356A (en) | 1996-07-09 |
FI943100A0 (en) | 1994-06-28 |
WO1995001342A1 (en) | 1995-01-12 |
JP2794342B2 (en) | 1998-09-03 |
CA2166320A1 (en) | 1995-01-12 |
EP0706516A1 (en) | 1996-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI961599A (en) | 1N-alkyl-N-arylpyrimidinamines and their derivatives | |
ATE162199T1 (en) | ANDROSTENE DERIVATIVES | |
FI941137A (en) | 2-Debenzoyl-2-acyltaxol derivatives and methods for their preparation | |
EE9700190A (en) | Pyrazol-4-yl-benzoyl derivatives and their use as herbicides | |
FI944310A0 (en) | Heteroarylamino- and heteroaryl-sulfonamido-substituted 3-benzylaminomethyl-piperidines and the like | |
FI953479A0 (en) | 1-Arylpyrimidine derivatives and their pharmaceutical use | |
ATA75293A (en) | INDOLDER DERIVATIVES | |
FI943100A (en) | Ansamycin derivatives as anthionogenic and anti-cancer agents | |
ITMI920408A1 (en) | BENZOPYRANIC AND BENZOTHIOPYRANIC DERIVATIVES | |
DE69330497D1 (en) | CHINAZOLIN DERIVATIVES | |
FI960867A (en) | Benzazepine derivative, its pharmaceutical composition and intermediate | |
DE59308714D1 (en) | CYCLOBUTANE-BENZENE DERIVATIVES | |
FI953021A0 (en) | 4-Benzoyl-isoxazole derivatives and their use as herbicides | |
FI960076A0 (en) | Novel (1-heteroazolyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents | |
FI955679A0 (en) | Piperidine derivatives, their preparation and use | |
BR9408029A (en) | N-substituted 3-azabicycloalkanes derivatives | |
NO952288D0 (en) | Benzazepinon derivatives | |
DE69313890D1 (en) | 5-aminoflavone derivatives | |
EE03614B1 (en) | Pyrazol-4-yl-benzoyl derivatives and their use as herbicides | |
DE9316475U1 (en) | Eye bolt | |
FI943513A0 (en) | 3-Phenylureidoazepin-2-ones and benzazepin-2-ones useful as cholecystokinin antagonists | |
DE59407726D1 (en) | 3-aryl-4-hydroxy-3-dihydrofuranone derivatives | |
ITMI941191A0 (en) | 1-B-METHYL-2-THIOL CARBAPEN DERIVATIVES | |
FI950303A0 (en) | Pyridoindolobenzodiazepines and derivatives as antipsychotics | |
DE69400388T2 (en) | Cyclohexenediol derivatives |